← Back to OrbiMed Advisors profile
OrbiMed Advisors related stories
All articles and analysis
DRI expects to launch Fund III later this yearThe Toronto-based drug royalty-focused firm closed its second fund on $701m last year and has been investing at a quick pace.
- Orbimed closes $500m venture fund
The New York-based firm says investors flocked to its third fund to focus on late-stage life science companies.
- Americas
Americas 2003-10-01 Staff Writer America Monitor Secrets worth keeping? Regardless of what will eventually be decided by a Californian superior
- Deal round-up 17/06/03
Coastview adds funds to ACADIA round; Atila, Index lead BeamExpress financing; Kiala lands XAnge-led E12.8m round; ISIS exits AIMS Group Services
- Deal round-up 06/03/02
US biotechnology company Agensys raises $43m from international venture capital firms.